A Justice Department probe of possible price collusion by generic drug companies could lead to criminal charges by the end of the year, Bloomberg News reported Thursday.

The investigation spans more than a dozen companies, Bloomberg reported, citing people familiar with the matter.

Shares of several generic drug makers declined following the report. Among them were Lannett Co. (LCI), which fell 26% to $17.30, Endo International PLC (ENDP), which was down 18% to $14.85 and Teva Pharmaceutical Industries Ltd. (TEVA), down 12% to $38.02.

Full story at http://www.bloomberg.com/news/articles/2016-11-03/u-s-charges-in-generic-drug-probe-said-to-be-filed-by-year-end

Write to nymonitoring@dowjones.com

(END) Dow Jones Newswires

November 03, 2016 15:53 ET (19:53 GMT)

Copyright (c) 2016 Dow Jones & Company, Inc.
Grafico Azioni Impax labs (NASDAQ:IPXLE)
Storico
Da Giu 2024 a Lug 2024 Clicca qui per i Grafici di Impax labs
Grafico Azioni Impax labs (NASDAQ:IPXLE)
Storico
Da Lug 2023 a Lug 2024 Clicca qui per i Grafici di Impax labs